Predictors of future exacerbations in a multi-ethnic Asian population with asthma

References

• Global Initiative for Asthma GINA. 2017 24/2/17. Available from: http://ginasthma.org/.
   Google Scholar
• Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, McLaurin K. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol. 2012;129:1229–35. doi:10.1016/j.jaci.2012.01.039. PMID:22326484.
   PubMed Web of Science ®Google Scholar
• Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet. 1999;353:364–9. doi:10.1016/S0140-6736(98)06128-5. PMID:9950442.
   PubMed Web of Science ®Google Scholar
• Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW,Casale TB, Chanez P, Enright PL, Gibson PG, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180:59–99. doi:10.1164/rccm.200801-060ST. PMID:19535666.
   PubMed Web of Science ®Google Scholar
• Al Badaai Y, Valdes CJ, Samaha M. Outcomes and cost benefits of functional endoscopic sinus surgery in severely asthmatic patients with chronic rhinosinusitis. J Laryngol Otol. 2014;128:512–7. doi:10.1017/S0022215114001133. PMID:24877745.
   PubMed Web of Science ®Google Scholar
• Tay TR, Radhakrishna N, Hore-Lacy F, Smith C, Hoy R, Dabscheck E, Hew M. Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life. Respirology. 2016;21:1384–90. doi:10.1111/resp.12838. PMID:27363539.
   PubMed Web of Science ®Google Scholar
• ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, Rabe KF, Bel EH. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J. 2005;26:812–8. doi:10.1183/09031936.05.00037905.
   PubMed Web of Science ®Google Scholar
• Denlinger LC, Phillips BR, Ramratnam S, Ross K, Bhakta NR, Cardet JC, Castro M, Peters SP, Phipatanakul W, Aujla S, et al. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations. Am J Respir Crit Care Med. 2017;195:302–13. PMID:27556234.
   PubMed Web of Science ®Google Scholar
• Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, Nizankowska-Mogilnicka E, Gjomarkaj M, Gaga M, Brusselle G, et al. Frequent exacerbators–a distinct phenotype of severe asthma. Clin Exp Allergy. 2014;44:212–21. doi:10.1111/cea.12179.
   PubMed Web of Science ®Google Scholar
• Yii ACA, Tan JHY, Lapperre TS, Chan AKW, Low SY, Ong TH, Tan KL, Chotirmall SH, Sterk PJ, Koh MS. Long-term future risk of severe exacerbations: Distinct 5-year trajectories of problematic asthma. Allergy. 2017;72:1398–405. doi:10.1111/all.13159. PMID:28295424.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Buhl R, O'Byrne PM, Humbert M, Reddel HK, Sears MR, Jenkins C, Harrison TW, Quirce S, Peterson S, et al. Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations. J Allergy Clin immunol. 2015;135:1457–64. e1454. doi:10.1016/j.jaci.2014.08.015. PMID:25258144.
   PubMed Web of Science ®Google Scholar
• Osborne ML, Pedula KL, O'Hollaren M, Ettinger KM, Stibolt T, Buist AS, Vollmer WM. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest. 2007;132:1151–61. doi:10.1378/chest.05-3084. PMID:17573515.
   PubMed Web of Science ®Google Scholar
• Quezada W, Kwak ES, Reibman J, Rogers L, Mastronarde J, Teague WG, Wei C, Holbrook JT, DiMango E. Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment. Ann Allergy, Asthma Immunol. 2016;116:112–7. doi:10.1016/j.anai.2015.11.011.
   PubMed Web of Science ®Google Scholar
• Netuveli G, Hurwitz B, Levy M, Fletcher M, Barnes G, Durham SR, Sheikh A. Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis. Lancet. 2005;365:312–7. doi:10.1016/S0140-6736(05)70195-1. PMID:15664226.
   PubMed Web of Science ®Google Scholar
• Ng TP, Lim TK, Abisheganaden J, Eng P, Sin FL. Factors associated with acute health care use in a national adult asthma management program. Ann Allergy, Asthma Immunol. 2006;97:784–93. doi:10.1016/S1081-1206(10)60970-2.
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. Can guideline-defined asthma control be achieved? the gaining optimal asthma control study. Am J Respir Crit Care Med. 2004;170:836–44. doi:10.1164/rccm.200401-033OC. PMID:15256389.
   PubMed Web of Science ®Google Scholar
• Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, Koskela H, Brannan JD, Freed R, Andersson M, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med. 2001;163:406–12. doi:10.1164/ajrccm.163.2.9912091. PMID:11179114.
   PubMed Web of Science ®Google Scholar
• Rank MA, Hagan JB, Park MA, Podjasek JC, Samant SA, Volcheck GW, Erwin PJ, West CP. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2013;131:724–9. doi:10.1016/j.jaci.2012.11.038. PMID:23321206.
   PubMed Web of Science ®Google Scholar
• Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Favro D, Lanfear DE, Pladevall M. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol. 2011;128:1185–91. e1182. doi:10.1016/j.jaci.2011.09.011. PMID:22019090.
   PubMed Web of Science ®Google Scholar
• Population trends. Singapore statistics 2016. Available from: http://www.singstat.gov.sg/docs/default-source/default-document-library/publications/publications_and_papers/population_and_population_structure/population2016.pdf
   Google Scholar
• Ginde AA, Espinola JA, Camargo CA, Jr. Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993–2005. J Allergy Clin Immunol. 2008;122:313–8. doi:10.1016/j.jaci.2008.04.024. PMID:18538382.
   PubMed Web of Science ®Google Scholar
• Crocker D, Brown C, Moolenaar R, Moorman J, Bailey C, Mannino D, Holguin F. Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey. Chest. 2009;136:1063–71. doi:10.1378/chest.09-0013. PMID:19567492.
   PubMed Web of Science ®Google Scholar
• Stanojevic S, Shah BR, Anand SS, Sears MR, Su J, Subbarao P. The burden of asthma among South Asian and Chinese populations residing in Ontario. Can Respir J. 2014;21:346–50. doi:10.1155/2014/160476.
   PubMed Web of Science ®Google Scholar
• Forno E, Celedon JC. Asthma and ethnic minorities: socioeconomic status and beyond. Curr Opin Allergy Clin immunol. 2009;9:154–60. doi:10.1097/ACI.0b013e3283292207. PMID:19326508.
   PubMed Web of Science ®Google Scholar
• Turrell G. Income non-reporting: implications for health inequalities research. J Epidemiol Community Health. 2000;54:207–14. doi:10.1136/jech.54.3.207. PMID:10746115.
   PubMed Web of Science ®Google Scholar
• Drug Subsidies & Schemes. Ministry of Health. 2017. Available from: https://www.moh.gov.sg/content/moh_web/home/costs_and_financing/schemes_subsidies/drug_subsidies.html.
   Google Scholar
• Ng TP, Hui KP, Tan WC. Prevalence of asthma and risk factors among Chinese, Malay, and Indian adults in Singapore. Thorax. 1994;49:347–51. doi:10.1136/thx.49.4.347. PMID:8202905.
   PubMed Web of Science ®Google Scholar
• Koo S, Gupta A, Fainardi V, Bossley C, Bush A, Saglani S, Fleming L. Ethnic variation in response to IM triamcinolone in children with severe therapy-resistant asthma. Chest. 2016;149:98–105. doi:10.1378/chest.14-3241. PMID:26378892.
   PubMed Web of Science ®Google Scholar
• Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, et al. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during long acting beta agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med. 2014;2:204–13. doi:10.1016/S2213-2600(13)70289-3. PMID:24621682.
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Castro M, Lehman E, Chinchilli VM, Sutherland ER, Denlinger L, Lazarus SC, Peters SP, Israel E. Impact of race on asthma treatment failures in the asthma clinical research network. Am J Respir Crit Care Med. 2011;184:1247–53. doi:10.1164/rccm.201103-0514OC. PMID:21885625.
   PubMed Web of Science ®Google Scholar
• Nyenhuis SM, Krishnan JA, Berry A, Calhoun WJ, Chinchilli VM, Engle L, Grossman N, Holguin F, Israel E, Kittles RA, et al. Race is associated with differences in airway inflammation in patients with asthma. J Allergy Clin Immunol. 2017;140:257–65. e211. doi:10.1016/j.jaci.2016.10.024. PMID:28069248.
   PubMed Web of Science ®Google Scholar
• Almoguera B, Vazquez L, Mentch F, Connolly J, Pacheco JA, Sundaresan AS, Peissig PL, Linneman JG, McCarty CA, Crosslin D, et al. Identification of four novel loci in asthma in European American and African American Populations. Am J Respir Crit Care Med. 2017;195:456–63. doi:10.1164/rccm.201604-0861OC. PMID:27611488.
   PubMed Web of Science ®Google Scholar
• Ko FW, Hui DS, Leung TF, Chu HY, Wong GW, Tung AH, Ngai JC, Ng SS, Lai CK. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations. Respirology. 2012;17:370–8. doi:10.1111/j.1440-1843.2011.02105.x. PMID:22107482.
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Busse WW, Wenzel SE, Belozeroff V, Weng HH, Feng J, Chon Y, Chiou CF, Globe D, Lin SL. Use of the asthma control questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol. 2011;127:167–72. doi:10.1016/j.jaci.2010.08.042. PMID:21093024.
   PubMed Web of Science ®Google Scholar
• Loymans RJ, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Assendelft WJ, Schermer TR, Chung KF, Sousa AR, Sterk PJ, Reddel HK, et al. Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model. Thorax. 2016;71:838–46. doi:10.1136/thoraxjnl-2015-208138. PMID:27044486.
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Trujillo-Torralbo MB, del-Rosario J, Bartlett NW, Edwards MR, Mallia P, Walton RP, Johnston SL. The influence of asthma control on the severity of virus-induced asthma exacerbations. J Allergy Clin Immunol. 2015;136:497–500. e493. doi:10.1016/j.jaci.2015.01.028. PMID:25772596.
   PubMed Web of Science ®Google Scholar
• Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF, Jr., Sorkness CA, Kraft M, Fish JE, Peters SP, Craig T, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. Jama. 2001;285:2583–93. doi:10.1001/jama.285.20.2583. PMID:11368732.
   PubMed Web of Science ®Google Scholar
• Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014;371:1198–207. doi:10.1056/NEJMoa1403290. PMID:25199059.
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47:410–9. doi:10.1183/13993003.01359-2015. PMID:26828055.
   PubMed Web of Science ®Google Scholar
• Haselkorn T, Zeiger RS, Chipps BE, Mink DR, Szefler SJ, Simons FE, Massanari M, Fish JE. Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2009;124:921–7. doi:10.1016/j.jaci.2009.09.006. PMID:19895984.
   PubMed Web of Science ®Google Scholar
• Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007;101:481–9. doi:10.1016/j.rmed.2006.07.005. PMID:16914299.
   PubMed Web of Science ®Google Scholar
• Schatz M, Meckley LM, Kim M, Stockwell BT, Castro M. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy. J Allergy Clin Immunol: In Practice. 2014;2:570–4. e571. doi:10.1016/j.jaip.2014.05.002.
   PubMed Web of Science ®Google Scholar
• Corren J. Exacerbation-prone asthma–intrinsic to severe disease or a unique phenotype? Clin Exp Allergy. 2014;44:152–3. doi:10.1111/cea.12256.
   PubMed Web of Science ®Google Scholar
• Loymans RJ, Sterk PJ. Exacerbation-prone asthma: a separate bioclinical phenotype? Am J Respir Crit Care Med. 2017;195:275–7. PMID:28145763.
   PubMed Web of Science ®Google Scholar
• Klok T, Kaptein AA, Duiverman EJ, Brand PL. It's the adherence, stupid (that determines asthma control in preschool children)! Eur Respir J. 2014;43:783–91. doi:10.1183/09031936.00054613. PMID:23845718.
   PubMed Web of Science ®Google Scholar
• Rust G, Zhang S, Reynolds J. Inhaled corticosteroid adherence and emergency department utilization among Medicaid-enrolled children with asthma. J Asthma. 2013;50:769–75. doi:10.3109/02770903.2013.799687.
   PubMed Web of Science ®Google Scholar
• Stanford RH, Nag A, Mapel DW, Lee TA, Rosiello R, Vekeman F, Gauthier-Loiselle M, Duh MS, Merrigan JF, Schatz M. Validation of a new risk measure for chronic obstructive pulmonary disease exacerbation using health insurance claims data. Ann Am Thorac Soc 2016;13:1067–75. doi:10.1513/AnnalsATS.201508-493OC. PMID:27070274.
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. BioMed Res Int. 2015;2015:217047. doi:10.1155/2015/217047. PMID:26539470.
   PubMed Web of Science ®Google Scholar
• Hagan JB, Samant SA, Volcheck GW, Li JT, Hagan CR, Erwin PJ, Rank MA. The risk of asthma exacerbation after reducing inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials. Allergy. 2014;69:510–6. doi:10.1111/all.12368. PMID:24571355.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380:651–9. doi:10.1016/S0140-6736(12)60988-X. PMID:22901886.
   PubMed Web of Science ®Google Scholar
• Walsh CJ, Zaihra T, Benedetti A, Fugere C, Olivenstein R, Lemiere C, Hamid Q, Martin JG. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils. Clin Exp Allergy. 2016;46:1291–302. doi:10.1111/cea.12762.
   PubMed Web of Science ®Google Scholar
• Healthcare Institution Statistics. Ministry of Health. 2017. Available from: https://www.moh.gov.sg/content/moh_web/home/statistics/healthcare_institutionstatistics.html.
   Google Scholar